Sandbox/general: Difference between revisions
< Sandbox
No edit summary |
No edit summary |
||
Line 70: | Line 70: | ||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Newborn Conjunctivitis}} | ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Newborn Conjunctivitis}} | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | ''''' | | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | ''''' [[Neisseria gonorrhoeae]] (after 2-5 days)''''' | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 25-50 mg/kg IV x 1 dose (not to exceed 125 mg)''''' | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 25-50 mg/kg IV x 1 dose (not to exceed 125 mg)''''' | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | ''''' | | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | ''''' [[Chlamydia trachomatis]] (after 3-10 days)''''' | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Erythromycin]] base or ethyl succinate syrup 12.5 mg/kg q6h x 14 days'''''<BR> OR <BR> ▸ '''''[[Azithromycin ]] suspension 20 mg/kg po q24h x 3 days''''' | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Erythromycin]] base or ethyl succinate syrup 12.5 mg/kg q6h x 14 days'''''<BR> OR <BR> ▸ '''''[[Azithromycin ]] suspension 20 mg/kg po q24h x 3 days''''' | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | ''''' | | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''[[Herpes simplex]] (after 2-16 days) †''''' | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Acyclovir]] 60 mg/kg/day IV divided into 3 daily doses'''''<BR> OR <BR> ▸ '''''[[Trifluridine]] OR [[Vidarabine]] as a topical antiviral therapy''''' | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Acyclovir]] 60 mg/kg/day IV divided into 3 daily doses'''''<BR> OR <BR> ▸ '''''[[Trifluridine]] OR [[Vidarabine]] as a topical antiviral therapy''''' |
Latest revision as of 20:17, 3 February 2014
▸ Click on the following categories to expand treatment regimens.
Conjunctivitis Medical Therapy ▸ Bacterial Conjunctivitis ▸ Newborn Conjunctivitis ▸ Viral Conjunctivitis |
|